nabumetone has been researched along with Ankylosing Spondylarthritis in 5 studies
Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nabumetone is a new non-steroidal anti-inflammatory drug advocated for use in the symptomatic treatment of rheumatic and inflammatory conditions." | 3.76 | Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases. ( Friedel, HA; Todd, PA, 1988) |
| "Forty-two patients with ankylosing spondylitis were entered into a double-blind study to compare treatment with indomethacin and a new non-steroidal anti-inflammatory drug, nabumetone." | 2.67 | A comparative study of nabumetone and indomethacin in ankylosing spondylitis. ( Palferman, TG; Webley, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, W | 1 |
| Wang, YM | 1 |
| Li, SL | 1 |
| Yan, M | 1 |
| Li, D | 1 |
| Chen, BY | 1 |
| Cheng, NN | 1 |
| Schwartzenberg, JM | 1 |
| Smith, DD | 1 |
| Lindsley, HB | 1 |
| Palferman, TG | 1 |
| Webley, M | 1 |
| Friedel, HA | 1 |
| Todd, PA | 1 |
| Jenner, PN | 1 |
| Johnson, ES | 1 |
1 review available for nabumetone and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; | 1988 |
3 trials available for nabumetone and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
A comparative study of nabumetone and indomethacin in ankylosing spondylitis.
Topics: Adult; Aged; Butanones; Double-Blind Method; Female; Humans; Indomethacin; Male; Middle Aged; Nabume | 1991 |
Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; | 1988 |
Review of the experience with nabumetone in clinical trials outside of the United States.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Athletic Injuries; Butanones; | 1987 |
2 other studies available for nabumetone and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Risk factors of adverse drug reaction from non-steroidal anti-inflammatory drugs in Shanghai patients with arthropathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheu | 2004 |
Bacillus Calmette-Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy.
Topics: Arthritis, Reactive; BCG Vaccine; Butanones; Carcinoma, Transitional Cell; Cytokines; Diagnosis, Dif | 1999 |